Tag: Serum Institute

Partners aim to provide potent neutralizing antibodies for COVID-19 pandemic response. The approach is complementary to future COVID-19 vaccines.........................

The collaboration between the Serum Institute of India, Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation will accelerate manufacturing and delivery of up to an additional 100 million doses of future safe and effective COVID-19 vaccines, priced at a maximum of US$ 3 per dose, for low- and middle-income countries in 2021..................

The Drugs Controller General of India has given the Serum Institute of India a green light to conduct phase 2 and 3 human trials of the Oxford-AstraZeneca COVID-19 vaccine candidate in India..................

Serum Institute of India has been supported under the Department of Biotechnology’s National Biopharma Mission for conduct of a multisite randomized double-blinded placebo-controlled phase III clinical trial of a recombinant BCG vaccine candidate, VPM1002.............................

On 14th July, 2020, Serum Institute of India, Pune has been granted permission to manufacture domestically developed first Pneumococcal Polysaccharide Conjugate Vaccine

Pune-based molecular diagnostics company Mylab Discovery Solutions has partnered with Serum Institute India’s CEO Adar Poonawalla and Abhijit Pawar, Chairman of APG to scale up the operations and escalate faster delivery of testing kits for the novel coronavirus (COVID-19)...............

In a bid to generate a vaccine candidate at the earliest, the Serum Institute of India-Codagenix developed novel coronavirus virus-vaccine strain is pegged as the first in its form to progress to the pre-clinical trial phase.......................

Serum Institute of India-Codagenix developed novel coronavirus virus-vaccine strain is first to progress to pre-clinical testing phase. The project has been running at an estimated cost of INR 300 crores......................

Mentioned Pushpa Vijayraghavan, Director, Sathguru Management Consultants who believes that the Indian vaccine industry broke the existing affordability barriers, making India a bright spot of the global vaccine map............

PATH is also working with Serum Institute to conduct an additional Phase 3 study to gather data required for World Health Organization (WHO) prequalification